國立虎尾科技大學 |

Multifaceted roles of crystallography in modern drug discovery

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Multifaceted roles of crystallography in modern drug discovery/ edited by Giovanna Scapin, Disha Patel, Eddy Arnold.
other author:	Scapin, Giovanna.
corporate name:	Workshop on the Preservation of Stability under Discretization
Published:	Dordrecht :Springer Netherlands : : 2015.,
Description:	xi, 240 p. :ill. (some col.), digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Pharmaceutical chemistry - Congresses. -
Online resource:	http://dx.doi.org/10.1007/978-94-017-9719-1
ISBN:	9789401797191 (electronic bk.)

Multifaceted roles of crystallography in modern drug discovery
Multifaceted roles of crystallography in modern drug discovery[electronic resource] /edited by Giovanna Scapin, Disha Patel, Eddy Arnold. - Dordrecht :Springer Netherlands :2015. - xi, 240 p. :ill. (some col.), digital ;24 cm. - NATO science for peace and security, series A, Chemistry and biology,1874-6489. - NATO science for peace and security series.Series A,Chemistry and biology..

Preface -- List of Contributors -- Engineering G Protein-Coupled Receptors for Drug Design -- Structural Insights into Activation and Allosteric Modulation of G Protein-Coupled Receptors -- Epigenetic Drug Discovery -- Crystallography and Biopharmaceuticals -- Structural Chemistry and Molecular Modeling in the Design of DPP4 Inhibitors -- Considerations for Structure-Based Drug Design Targeting HIV-1 Reverse Transcriptase.-Protein-Ligand Interactions as the Basis for Drug Action -- The Protein Data Bank: Overview and Tools for Drug Discovery -- Small Molecule Crystal Structures in Drug Discovery -- Protein Aggregation and its Prediction -- Importance of Protonation States for the Binding of Ligands to Pharmaceutical Targets -- Protein-Protein Interactions: Structures and Druggability -- Achieving High Quality Ligand Chemistry in Protein-Ligand Crystal Structures for Drug Design -- Molecular Obesity, Potency and Other Addictions in Drug Discovery -- Adventures in Small Molecule Fragment Screening by X-ray Crystallography for Drug Discovery -- Structure-Based Drug Design to Perturb Function of a tRNA-Modifying Enzyme by Active Site and Protein-Protein Interface Inhibition -- Molecular Interaction Analysis for Discovery of Drugs Targeting Enzymes and for Resolving Biological Function.

The present work offers a snapshot of the state-of-the-art of crystallographic, analytical, and computational methods used in modern drug design and development. Topics discussed include: drug design against complex systems (membrane proteins, cell surface receptors, epigenetic targets, and ribosomes); modulation of protein-protein interactions; the impact of small molecule structures in drug discovery and the application of concepts such as molecular geometry, conformation, and flexibility to drug design; methodologies for understanding and characterizing protein states and protein-ligand interactions during the drug design process; and monoclonal antibody therapies. These methods are illustrated through their application to problems of medical and biological significance, such as viral and bacterial infections, diabetes, autoimmune disease, and CNS diseases. As approaches to drug discovery have changed over time, so have the methodologies used to solve the varied, new, and difficult problems encountered in drug discovery. In recent years we have seen great progress in the fields of genetics, biology, chemistry, and medicine, but there are still many unmet medical needs, from bacterial infections to cancer to chronic maladies, that require novel, different, or better therapies. This work will be of interest to researchers and policy makers interested in the latest developments in drug design.

ISBN: 9789401797191 (electronic bk.)

Standard No.: 10.1007/978-94-017-9719-1doiSubjects--Topical Terms:

791593
Pharmaceutical chemistry
--Congresses.

LC Class. No.: RS420

Dewey Class. No.: 615.19

Multifaceted roles of crystallography in modern drug discovery
LDR:03741nam a2200301 a 4500 001 836243
003 DE-He213
005 20150911160737.0
006 m d
007 cr nn 008maaau
008 160421s2015 ne s 0 eng d
020 $a 9789401797191 (electronic bk.)
020 $a 9789401797184 (paper)
024 7 $a 10.1007/978-94-017-9719-1 $2 doi
035 $a 978-94-017-9719-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RS420
082 0 4 $a 615.19 $2 23
090 $a RS420 $b .N279 2014
111 2 $a Workshop on the Preservation of Stability under Discretization $d (2001 : $c Fort Collins, Colo.) $3 527686
245 1 0 $a Multifaceted roles of crystallography in modern drug discovery $h [electronic resource] / $c edited by Giovanna Scapin, Disha Patel, Eddy Arnold.
260 $a Dordrecht : $c 2015. $b Springer Netherlands : $b Imprint: Springer,
300 $a xi, 240 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a NATO science for peace and security, series A, Chemistry and biology, $x 1874-6489
505 0 $a Preface -- List of Contributors -- Engineering G Protein-Coupled Receptors for Drug Design -- Structural Insights into Activation and Allosteric Modulation of G Protein-Coupled Receptors -- Epigenetic Drug Discovery -- Crystallography and Biopharmaceuticals -- Structural Chemistry and Molecular Modeling in the Design of DPP4 Inhibitors -- Considerations for Structure-Based Drug Design Targeting HIV-1 Reverse Transcriptase.-Protein-Ligand Interactions as the Basis for Drug Action -- The Protein Data Bank: Overview and Tools for Drug Discovery -- Small Molecule Crystal Structures in Drug Discovery -- Protein Aggregation and its Prediction -- Importance of Protonation States for the Binding of Ligands to Pharmaceutical Targets -- Protein-Protein Interactions: Structures and Druggability -- Achieving High Quality Ligand Chemistry in Protein-Ligand Crystal Structures for Drug Design -- Molecular Obesity, Potency and Other Addictions in Drug Discovery -- Adventures in Small Molecule Fragment Screening by X-ray Crystallography for Drug Discovery -- Structure-Based Drug Design to Perturb Function of a tRNA-Modifying Enzyme by Active Site and Protein-Protein Interface Inhibition -- Molecular Interaction Analysis for Discovery of Drugs Targeting Enzymes and for Resolving Biological Function.
520 $a The present work offers a snapshot of the state-of-the-art of crystallographic, analytical, and computational methods used in modern drug design and development. Topics discussed include: drug design against complex systems (membrane proteins, cell surface receptors, epigenetic targets, and ribosomes); modulation of protein-protein interactions; the impact of small molecule structures in drug discovery and the application of concepts such as molecular geometry, conformation, and flexibility to drug design; methodologies for understanding and characterizing protein states and protein-ligand interactions during the drug design process; and monoclonal antibody therapies. These methods are illustrated through their application to problems of medical and biological significance, such as viral and bacterial infections, diabetes, autoimmune disease, and CNS diseases. As approaches to drug discovery have changed over time, so have the methodologies used to solve the varied, new, and difficult problems encountered in drug discovery. In recent years we have seen great progress in the fields of genetics, biology, chemistry, and medicine, but there are still many unmet medical needs, from bacterial infections to cancer to chronic maladies, that require novel, different, or better therapies. This work will be of interest to researchers and policy makers interested in the latest developments in drug design.
650 0 $a Pharmaceutical chemistry $v Congresses. $3 791593
650 0 $a Drugs $x Design $v Handbooks, manuals, etc. $3 583329 $3 737646
650 0 $a Drug development $v Congresses. $3 668925 $3 735772
650 0 $a Crystallography $3 671002
650 0 $a Structural bioinformatics $v Congresses. $3 1066194
650 1 4 $a Life Sciences. $3 593888
650 2 4 $a Protein-Ligand Interactions. $3 882815
650 2 4 $a Medicinal Chemistry. $3 668872
650 2 4 $a Molecular Medicine. $3 668353
650 2 4 $a Theoretical and Computational Chemistry. $3 670313
650 2 4 $a Crystallography. $3 583281
700 1 $a Scapin, Giovanna. $3 1066192
700 1 $a Patel, Disha. $3 1066193
700 1 $a Arnold, Eddy. $3 889731
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
830 0 $a NATO science for peace and security series. $n Series A, $p Chemistry and biology. $3 882039
856 4 0 $u http://dx.doi.org/10.1007/978-94-017-9719-1
950 $a Biomedical and Life Sciences (Springer-11642)